Cgrpr Calcitonin gene-related peptide (CGRP) is a 37-amino acid neuropeptide that plays a significant role in various physiological processes, most notably in the modulation of pain and vascular tone. Discovered decades ago, CGRP has emerged as a critical focus in understanding conditions like migraine, but its influence extends to other bodily systems, including the cardiovascular and immune systems, and its involvement in inflammation and nerve injury. The identification of CGRP's potent vasodilatory effects and its association with migraine attacks has led to the development of targeted therapies that aim to block its action, offering new hope for individuals suffering from these debilitating conditions.
CGRP is derived from the calcitonin gene through alternative RNA processing, resulting in two main isoforms: alpha-CGRP and beta-CGRP. This neuropeptide is widely distributed throughout the central and peripheral nervous systems, found in sensory neurons, motor neurons, and other cell typesCalcitonin Gene-Related Peptide, kurz CGRP, ist ein Neuropeptid, das aus 37 Aminosäuren besteht. Es wird durch dasselbe Gen wie das Hormon Calcitonin kodiert.. Its release can trigger a cascade of events, including intense inflammation in the brain's coverings, which is a hallmark of migraineCGRP Inhibitors: What They Are, Uses & Side Effects - Cleveland Clinic. Beyond its role in pain pathways, CGRP is also implicated in regulating appetite, gastric acid release, heart rate, and temperature homeostasis, underscoring its broad systemic impact.
The link between CGRP and migraine has been extensively studied, solidifying its position as a key mediator in migraine pathophysiology. During a migraine attack, CGRP is released from trigeminal nerve endings and causes vasodilation of cranial blood vessels, leading to inflammation and the characteristic throbbing painCalcitonin gene-related peptide (CGRP)is involved in central and peripheral sensitizationduring inflammation and nerve injury.. This understanding has revolutionized migraine treatment, paving the way for novel therapeutic strategies.
The growing knowledge of CGRP's role in migraine has spurred the development of two primary classes of drugs: CGRP monoclonal antibodies (mAbs) and CGRP receptor antagonists (gepants).
* CGRP Monoclonal Antibodies (mAbs): These injectable medications are designed to target and block CGRP itself or its receptor. By preventing CGRP from binding to its receptor, these antibodies effectively reduce the signaling pathways that contribute to migraine pain.Calcitonin Gene-Related Peptide (CGRP) Antagonists They are typically used for migraine preventionCalcitonin gene-related peptide (CGRP) is a 37-amino acid neuropeptide produced by tissue specific processing of the calcitonin gene and is the major product ....
* CGRP Receptor Antagonists (Gepants): Gepants are oral medications that work by blocking the CGRP receptor, thereby preventing CGRP from exerting its effects. This class of drugs can be used for both the acute treatment of migraine attacks and, in some cases, for prevention.When CGRP is released, it causes intense inflammation in the coverings of the brain(the meninges), and for most migraine patients, causes the pain of a ... Examples include rimegepant.
These targeted therapies represent a significant advancement in migraine management, offering effective relief for many patients who have not found success with traditional treatments.
While migraine is the most prominent condition linked to CGRP, its influence extends to other areas:
* Vascular Function: As a potent vasodilator, CGRP plays a crucial role in regulating blood flow throughout the body. Its systemic effects on the cardiovascular system are significant.
* Inflammation and Nerve Injury: CGRP is involved in central and peripheral sensitization during inflammation and nerve injury, suggesting a role in modulating inflammatory responses and pain perception following tissue damage.
* Immune System Modulation: Emerging research indicates that CGRP may also influence the function of immune system components, including T cells, hinting at a broader role in immune regulation.
Despite the progress made in understanding and targeting CGRP, some challenges remain. The concentration of CGRP in human plasma can be inconsistent, making diagnostic measurements difficult. Nevertheless, the continued exploration of CGRP's multifaceted roles promises further insights into various physiological and pathological processes. Research is ongoing to explore its potential involvement in other conditions and to refine existing therapies for even greater efficacy and patient benefit作者：JC Ray·2021·被引用次数：73—After 30 years of translational research,calcitonin gene-related peptide (CGRP) inhibitorshave emerged as a promising new tool in the prevention of migraine.. The journey of understanding CGRP, from its discovery to its therapeutic applications, highlights the power of scientific research in unraveling complex biological mechanisms and translating that knowledge into life-changing treatments.
Join the newsletter to receive news, updates, new products and freebies in your inbox.